🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareSemaglutide and gallbladder disease risk — my results so far Page 4

Semaglutide and gallbladder disease risk — my results so far

lisa_labSD Wed, Jun 4, 2025 at 10:48 PM 44 replies 2,339 viewsPage 4 of 9
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
Jun 22, 2025 at 7:46 AM#16

Adding the clinical framing, because it changes how the question reads. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

9 7DebRD_ATL, KristenIndy, MarkLI_maint and 6 others
Reply Quote Save Share Report
JessicaH_TX
Senior Member
4,123
13,456
Dec 2023
Houston, TX
Jun 25, 2025 at 3:31 AM#17
wendy_avl said:
Gallbladder warning for gallbladder risk: rapid weight loss increases gallstone risk regardless of method.

Thank you — that is the clearest version of this I have read, and I have read a lot of them. Adding it to my notes with a link back to this thread.

Last edited: Jun 25, 2025 at 7:31 AM
10 8sarah_TO, wendy_avl, jason_paloalto and 7 others
Reply Quote Save Share Report
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Jun 27, 2025 at 11:16 PM#18

Adding the clinical framing, because it changes how the question reads. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

Happy to go further on any of that.

Last edited: Jun 28, 2025 at 5:16 AM
11 9WendyG_ATL, SaraMom3, Dr.MetabolicMD and 8 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
chris_chi24
Member
389
1,678
Sep 2024
Chicago, IL
Jun 30, 2025 at 6:58 PM#19
Dr.PathRoch said:
The mechanism and the magnitude are separate questions.

This is my experience too, for whatever a second data point is worth. Nothing to add that would improve it.

Last edited: Jun 30, 2025 at 9:58 PM
12 10PurityPaulOR, MaxMetOK, MounjBrad and 9 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jul 3, 2025 at 2:39 PM#20

Moderator note: the sourcing question belongs in the vendor section and has been split out. Thread quality here is what the rules are for. Keep it up.

34 7PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 31 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register